Embecta (EMBC) Share-based Compensation (2020 - 2026)
Embecta (EMBC) reported Share-based Compensation of -$1.0 million for Q1 2026, down 211.11% on a YoY basis from $900000.0 in Q1 2025, and down 116.95% sequentially from $5.9 million in Q4 2025.
Embecta (EMBC) Share-based Compensation (2020 - 2026) Analysis & Trends
Embecta (EMBC) has 7 years of Share-based Compensation data on file, last reported at -$1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 211.11% year-over-year to -$1.0 million; the trailing twelve-month figure through Mar 2026 stood at $31.9 million (up 551.02% YoY), and the FY2025 full-year result was $31.6 million, up 953.33% from the prior year.
- Share-based Compensation eased to -$1.0 million in Q1 2026, from $5.9 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $17.5 million in Q2 2025 to a low of -$17.1 million in Q3 2024.
- A 5-year average of $2.3 million and a median of $900000.0 in 2025 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 4250.0% in 2024, while the deepest fall reached 8650.0% in 2024.
- Tracing EMBC's Share-based Compensation over 5 years: stood at $2.8 million in 2022, then surged by 160.71% to $7.3 million in 2023, then tumbled by 49.32% to $3.7 million in 2024, then surged by 59.46% to $5.9 million in 2025, then plunged by 116.95% to -$1.0 million in 2026.
- Business Quant data shows EMBC's Share-based Compensation at -$1.0 million in Q1 2026, $5.9 million in Q4 2025, and $9.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 45.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 13.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 58.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 26.79 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 51.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.92 Mn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | -1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Sep 30, 2025 | 9.50 Mn |
| Sep 30, 2025 | 9.50 Mn |
| Jun 30, 2025 | 17.50 Mn |
| Jun 30, 2025 | 17.50 Mn |
| Mar 31, 2025 | 900,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 3.70 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | -17.10 Mn |
| Sep 30, 2024 | -17.10 Mn |
| Jun 30, 2024 | 17.40 Mn |
| Jun 30, 2024 | 17.40 Mn |
| Mar 31, 2024 | -4.60 Mn |
| Mar 31, 2024 | -4.60 Mn |
| Dec 31, 2023 | 7.30 Mn |
| Dec 31, 2023 | 7.30 Mn |